These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Continuous non chronomodulated infusion of floxuridine in metastatic renal cell carcinoma (MRCC): report of 17 cases. Baiocchi C; Landonio G; Cacioppo C; Calgaro M; Cattaneo D; Ferrari M; Majno M Tumori; 1996; 82(3):225-7. PubMed ID: 8693598 [TBL] [Abstract][Full Text] [Related]
10. Circadian continuous chemotherapy of renal cell carcinoma with an implantable, programmable infusion pump. Damascelli B; Marchianò A; Spreafico C; Lutman R; Salvetti M; Bonalumi MG; Mauri M; Garbagnati F; Del Nero A; Comeri G Cancer; 1990 Jul; 66(2):237-41. PubMed ID: 2142443 [TBL] [Abstract][Full Text] [Related]
11. Chronomodulated 5-day infusion of floxuridine and L-folinic acid in patients with advanced malignancies: a feasibility and tolerability study. Garufi C; Lévi F; Giunta S; Aschelter A; Pace R; Nisticò C; Terzoli E J Infus Chemother; 1995; 5(3 Suppl 1):134-7. PubMed ID: 8528973 [TBL] [Abstract][Full Text] [Related]
12. Non invasive ventilation in the treatment of FUdr-induced lesional pulmonary oedema. Conti G; Spadetta G; Rocco M; Antonelli M; Ruscio L; Gionfrida E; Angiuli G Minerva Anestesiol; 2000; 66(7-8):561-4. PubMed ID: 10965737 [TBL] [Abstract][Full Text] [Related]
13. Neurologic toxicity associated with hepatic artery infusion HAI of FUdR. Taylor HG; Wolf CR; Maitland CG Cancer Chemother Pharmacol; 1986; 17(3):292-3. PubMed ID: 2943526 [TBL] [Abstract][Full Text] [Related]
14. A phase II study of constant-infusion floxuridine for the treatment of metastatic renal cell carcinoma. Wilkinson MJ; Frye JW; Small EJ; Venook AP; Carroll PR; Ernest ML; Stagg RJ Cancer; 1993 Jun; 71(11):3601-4. PubMed ID: 8490909 [TBL] [Abstract][Full Text] [Related]
15. Toxicities and complications of implanted pump hepatic arterial and intravenous floxuridine infusion. Hohn DC; Rayner AA; Economou JS; Ignoffo RJ; Lewis BJ; Stagg RJ Cancer; 1986 Feb; 57(3):465-70. PubMed ID: 2935242 [TBL] [Abstract][Full Text] [Related]
16. Infusional floxuridine-based therapy for patients with metastatic renal cell carcinoma. Reese DM; Corry M; Small EJ Cancer; 2000 Mar; 88(6):1310-6. PubMed ID: 10717611 [TBL] [Abstract][Full Text] [Related]
17. [Continuous sinusoid systemic Fudr infusion in advanced colorectal carcinoma. Preliminary experience]. Civalleri D; Cavallini M; Tirindelli Danesi D; Decian F; Depaoli M; Balletto N Minerva Chir; 1992 May; 47(9):853-8. PubMed ID: 1535695 [TBL] [Abstract][Full Text] [Related]
19. Flexibility and efficacy of automatic continuous fluorodeoxyuridine infusion in metastases from a renal cell carcinoma. Damascelli B; Marchianò A; Frigerio LF; Salvetti M; Spreafico C; Garbagnati F; Zanoni F; Radice F Cancer; 1991 Sep; 68(5):995-8. PubMed ID: 1833043 [TBL] [Abstract][Full Text] [Related]
20. A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial. Hohn DC; Stagg RJ; Friedman MA; Hannigan JF; Rayner A; Ignoffo RJ; Acord P; Lewis BJ J Clin Oncol; 1989 Nov; 7(11):1646-54. PubMed ID: 2530317 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]